What is the maximum recommended dose of betahistine for an adult with vertigo or Ménière’s disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Maximum Recommended Dose of Betahistine

The maximum dose of betahistine studied in high-quality trials is 144 mg/day, though the most commonly used and recommended dose is 48 mg/day. 1

Dosing Evidence from Guidelines

The 2020 American Academy of Otolaryngology-Head and Neck Surgery clinical practice guideline on Ménière's disease references the BEMED trial, which is the highest quality study available on betahistine dosing. This well-designed, double-blind RCT evaluated three groups:

  • Low-dose betahistine: 48 mg/day
  • High-dose betahistine: 144 mg/day
  • Placebo

1

The trial found no significant differences between any of these doses and placebo for vertigo control over 9 months, though all groups showed improvement. Importantly, the 144 mg/day dose was safely administered without serious adverse events, establishing this as a tested upper limit. 1

Practical Dosing Recommendations

In clinical practice, 48 mg/day is the standard maximum dose used, typically divided as:

  • 24 mg twice daily (traditional formulation), or
  • 48 mg once daily (modified-release formulation)

2, 3, 4

While doses up to 144 mg/day have been studied and appear safe, there is no evidence that higher doses provide additional benefit over 48 mg/day. 1

Safety Profile

Betahistine demonstrates an excellent safety profile across the dose range studied. The most commonly reported adverse effects include:

  • Headache
  • Balance disorder
  • Nausea
  • Upper gastrointestinal symptoms
  • Palpitations

1

Contraindications and cautions:

  • Avoid in patients with pheochromocytoma
  • Use with caution in patients with asthma or history of peptic ulcer disease

1

Important Clinical Context

The guideline committee acknowledges they "are unable to make a definitive statement on use of betahistine to control MD symptoms" given that the highest quality evidence (BEMED trial) showed no superiority over placebo. 1 However, betahistine remains widely used with minimal risk of harm, and some lower-quality studies suggested benefit.

Treatment duration: Most studies evaluated 2-12 weeks of therapy, though the BEMED trial extended to 9 months. There are no clear data on optimal treatment duration. 1

References

1
Guideline

clinical practice guideline: ménière's disease.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2020

Related Questions

How long should I use betahistine for vertigo?
Is Dizinel and Serc (Betahistine) compatible?
What is the recommended dosing and safety information for Betahistine dehydrochloride 8 mg tablets for vertigo due to Ménière’s disease?
What is the pediatric dosage of Beta-Histidine (Histidine)?
What is the recommended dosage of betahistine (Betahistine) for the treatment of Benign Paroxysmal Positional Vertigo (BPPV)?
In an 84-year-old woman with borderline hypercalcemia, markedly elevated intact parathyroid hormone (PTH), and mildly impaired renal function (creatinine 1.24 mg/dL), what is the most likely diagnosis and how should it be evaluated and managed?
What is the appropriate pharmacologic agent for rhythm control in an adult patient with atrial fibrillation who has no structural heart disease, coronary artery disease, left ventricular dysfunction, or prolonged QT interval?
In an 84‑year‑old woman with borderline hypercalcemia, markedly elevated intact parathyroid hormone, and mild renal impairment, is thyroid scintigraphy indicated?
In a 67‑year‑old woman with a history of cerebrovascular accident, coronary artery disease, preserved ejection fraction, dilated right and left atria, severe mitral regurgitation, and atrial fibrillation, can amiodarone be combined with diltiazem and a direct oral anticoagulant such as rivaroxaban?
Are total parenteral nutrition (TPN), D5% normal saline (D5NS), levofloxacin, vasocand (vasopressor), and dexmedetomidine (Precedex) compatible for co‑infusion?
How should dexmedetomidine (Precedex) and 5% dextrose in normal saline (D5NS) be administered using a triple‑lumen catheter?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.